Correlation Between Fortress Biotech and Opthea

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Fortress Biotech and Opthea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fortress Biotech and Opthea into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fortress Biotech and Opthea, you can compare the effects of market volatilities on Fortress Biotech and Opthea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fortress Biotech with a short position of Opthea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fortress Biotech and Opthea.

Diversification Opportunities for Fortress Biotech and Opthea

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Fortress and Opthea is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Fortress Biotech and Opthea in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opthea and Fortress Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fortress Biotech are associated (or correlated) with Opthea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opthea has no effect on the direction of Fortress Biotech i.e., Fortress Biotech and Opthea go up and down completely randomly.

Pair Corralation between Fortress Biotech and Opthea

Given the investment horizon of 90 days Fortress Biotech is expected to under-perform the Opthea. But the stock apears to be less risky and, when comparing its historical volatility, Fortress Biotech is 1.0 times less risky than Opthea. The stock trades about -0.08 of its potential returns per unit of risk. The Opthea is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  297.00  in Opthea on August 25, 2024 and sell it today you would earn a total of  19.00  from holding Opthea or generate 6.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Fortress Biotech  vs.  Opthea

 Performance 
       Timeline  
Fortress Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fortress Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Opthea 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Opthea are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Opthea may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Fortress Biotech and Opthea Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Fortress Biotech and Opthea

The main advantage of trading using opposite Fortress Biotech and Opthea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fortress Biotech position performs unexpectedly, Opthea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opthea will offset losses from the drop in Opthea's long position.
The idea behind Fortress Biotech and Opthea pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Correlations
Find global opportunities by holding instruments from different markets